191 related articles for article (PubMed ID: 1964794)
1. Autocrine growth stimulation by secreted Kaposi fibroblast growth factor but not by endogenous basic fibroblast growth factor.
Wellstein A; Lupu R; Zugmaier G; Flamm SL; Cheville AL; Delli Bovi P; Basilico C; Lippman ME; Kern FG
Cell Growth Differ; 1990 Feb; 1(2):63-71. PubMed ID: 1964794
[TBL] [Abstract][Full Text] [Related]
2. Cell motility, invasion, and malignancy induced by overexpression of K-FGF or bFGF.
Taylor WR; Greenberg AH; Turley EA; Wright JA
Exp Cell Res; 1993 Feb; 204(2):295-301. PubMed ID: 8440326
[TBL] [Abstract][Full Text] [Related]
3. Enhanced invasion and tumor growth of fibroblast growth factor 8b-overexpressing MCF-7 human breast cancer cells.
Ruohola JK; Viitanen TP; Valve EM; Seppänen JA; Loponen NT; Keskitalo JJ; Lakkakorpi PT; Härkönen PL
Cancer Res; 2001 May; 61(10):4229-37. PubMed ID: 11358849
[TBL] [Abstract][Full Text] [Related]
4. Rapid tumor development and potent vascularization are independent events in carcinoma producing FGF-1 or FGF-2.
Billottet C; Janji B; Thiery JP; Jouanneau J
Oncogene; 2002 Nov; 21(53):8128-39. PubMed ID: 12444548
[TBL] [Abstract][Full Text] [Related]
5. Angiogenesis by fibroblast growth factor 4 is mediated through an autocrine up-regulation of vascular endothelial growth factor expression.
Deroanne CF; Hajitou A; Calberg-Bacq CM; Nusgens BV; Lapière CM
Cancer Res; 1997 Dec; 57(24):5590-7. PubMed ID: 9407972
[TBL] [Abstract][Full Text] [Related]
6. Suramin interrupts androgen-inducible autocrine loop involving heparin binding growth factor in mouse mammary cancer (Shionogi carcinoma 115) cells.
Kasayama S; Saito H; Kouhara H; Sumitani S; Sato B
J Cell Physiol; 1993 Feb; 154(2):254-61. PubMed ID: 7678839
[TBL] [Abstract][Full Text] [Related]
7. FGF-8b increases angiogenic capacity and tumor growth of androgen-regulated S115 breast cancer cells.
Mattila MM; Ruohola JK; Valve EM; Tasanen MJ; Seppänen JA; Härkönen PL
Oncogene; 2001 May; 20(22):2791-804. PubMed ID: 11420691
[TBL] [Abstract][Full Text] [Related]
8. Modulation of growth of human carcinoma SW-13 cells by heparin and growth factors.
Halper J; Carter BJ
J Cell Physiol; 1989 Oct; 141(1):16-23. PubMed ID: 2777898
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of basic fibroblast growth factor in MCF-7 human breast cancer cells: lack of correlation between inhibition of cell growth and MAP kinase activation.
Wieder R; Fenig E; Wang H; Wang Q; Paglin S; Menzel T; Gabrilove J; Fuks Z; Yahalom J
J Cell Physiol; 1998 Dec; 177(3):411-25. PubMed ID: 9808150
[TBL] [Abstract][Full Text] [Related]
10. Growth advantage and vascularization induced by basic fibroblast growth factor overexpression in endometrial HEC-1-B cells: an export-dependent mechanism of action.
Coltrini D; Gualandris A; Nelli EE; Parolini S; Molinari-Tosatti MP; Quarto N; Ziche M; Giavazzi R; Presta M
Cancer Res; 1995 Oct; 55(20):4729-38. PubMed ID: 7553656
[TBL] [Abstract][Full Text] [Related]
11. A novel recombinant basic fibroblast growth factor and its secretion.
Sohn YD; Lim HJ; Hwang KC; Kwon JH; Park HY; Chung KH; Cho SY; Jang Y
Biochem Biophys Res Commun; 2001 Jun; 284(4):931-6. PubMed ID: 11409882
[TBL] [Abstract][Full Text] [Related]
12. Tumor growth dependent on Kaposi's sarcoma-derived fibroblast growth factor inhibited by pentosan polysulfate.
Wellstein A; Zugmaier G; Califano JA; Kern F; Paik S; Lippman ME
J Natl Cancer Inst; 1991 May; 83(10):716-20. PubMed ID: 1708834
[TBL] [Abstract][Full Text] [Related]
13. Basic fibroblast growth factor confers a less malignant phenotype in MDA-MB-231 human breast cancer cells.
Korah RM; Sysounthone V; Golowa Y; Wieder R
Cancer Res; 2000 Feb; 60(3):733-40. PubMed ID: 10676661
[TBL] [Abstract][Full Text] [Related]
14. Constitutive expression of fibroblast growth factor-4 does not alter the growth or the differentiation of embryonal carcinoma cells.
Miller K; Rizzino A
Cell Growth Differ; 1996 Feb; 7(2):203-11. PubMed ID: 8822204
[TBL] [Abstract][Full Text] [Related]
15. Fibroblast growth factor 4 transfection of MCF-7 cells produces cell lines that are tumorigenic and metastatic in ovariectomized or tamoxifen-treated athymic nude mice.
McLeskey SW; Kurebayashi J; Honig SF; Zwiebel J; Lippman ME; Dickson RB; Kern FG
Cancer Res; 1993 May; 53(9):2168-77. PubMed ID: 8481920
[TBL] [Abstract][Full Text] [Related]
16. Identification of basic fibroblast growth factor sensitivity and receptor and ligand expression in human colon tumor cell lines.
New BA; Yeoman LC
J Cell Physiol; 1992 Feb; 150(2):320-6. PubMed ID: 1310324
[TBL] [Abstract][Full Text] [Related]
17. Stromal influences on transformation of human mammary epithelial cells overexpressing c-myc and SV40T.
Valverius EM; Ciardiello F; Heldin NE; Blondel B; Merlo G; Smith G; Stampfer MR; Lippman ME; Dickson RB; Salomon DS
J Cell Physiol; 1990 Nov; 145(2):207-16. PubMed ID: 2174061
[TBL] [Abstract][Full Text] [Related]
18. Induction of cell death by basic fibroblast growth factor in Ewing's sarcoma.
Sturla LM; Westwood G; Selby PJ; Lewis IJ; Burchill SA
Cancer Res; 2000 Nov; 60(21):6160-70. PubMed ID: 11085540
[TBL] [Abstract][Full Text] [Related]
19. Responsiveness of developing dental tissues to fibroblast growth factors: expression of splicing alternatives of FGFR1, -2, -3, and of FGFR4; and stimulation of cell proliferation by FGF-2, -4, -8, and -9.
Kettunen P; Karavanova I; Thesleff I
Dev Genet; 1998; 22(4):374-85. PubMed ID: 9664689
[TBL] [Abstract][Full Text] [Related]
20. Basic fibroblast growth factor and receptor expression in human ovarian cancer.
Crickard K; Gross JL; Crickard U; Yoonessi M; Lele S; Herblin WF; Eidsvoog K
Gynecol Oncol; 1994 Nov; 55(2):277-84. PubMed ID: 7959296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]